Product details

Gamma-Dynacare performs laboratory testing covering blood, urine and tissue samples for evidence of disease and abnormality. Traditionally, all testing was performed on behalf of physicians and paid from public funds through provincial health insurance plans. Health insurance plans have frozen payments to Gamma-Dynacare. The firm has developed expertise and systems to test individuals as drug free as part of employment conditions. The growth potential for random drug testing is large but margins are considerably less than the normal business. The decision-maker wishes to know the costs of delivering random drug testing and using this information to develop a marketing strategy to address this market. Given public sensitivities to random drug testing, this market has a risk that consumer groups and quasi-government authorities may render the testing inappropriate on public interest grounds.